sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 1,1'-Methylenedi-2-naphthol

1,1'-Methylenedi-2-naphthol

CAS No.:
1096-84-0
Catalog Number:
AG003D9B
Molecular Formula:
C21H16O2
Molecular Weight:
300.3505
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25g
>97.0%(GC)
1 week
United States
$316
- +
Product Description
Catalog Number:
AG003D9B
Chemical Name:
1,1'-Methylenedi-2-naphthol
CAS Number:
1096-84-0
Molecular Formula:
C21H16O2
Molecular Weight:
300.3505
MDL Number:
MFCD00046470
IUPAC Name:
1-[(2-hydroxynaphthalen-1-yl)methyl]naphthalen-2-ol
InChI:
InChI=1S/C21H16O2/c22-20-11-9-14-5-1-3-7-16(14)18(20)13-19-17-8-4-2-6-15(17)10-12-21(19)23/h1-12,22-23H,13H2
InChI Key:
ZPANWZBSGMDWON-UHFFFAOYSA-N
SMILES:
Oc1ccc2c(c1Cc1c(O)ccc3c1cccc3)cccc2
EC Number:
214-145-4
Properties
Complexity:
359  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
300.115g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
300.357g/mol
Monoisotopic Mass:
300.115g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
40.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.6  
Literature
Title Journal
Discovery of novel SERCA inhibitors by virtual screening of a large compound library. European journal of medicinal chemistry 20110501
A highly efficient green synthesis of 1, 8-dioxo-octahydroxanthenes. Chemistry Central journal 20110101
Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation. Bioorganic & medicinal chemistry 20090201
ST1859 reduces prion infectivity and increase survival in experimental scrapie. Archives of virology 20090101
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clinical pharmacology and therapeutics 20060901
Properties